Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Lab - Quaterly Results

Date: 07-05-2024
A fair growth of 12.09% in the revenue at Rs. 51048.00 millions was reported in the March 2024 quarter as compared to Rs. 45540.00 millions during year-ago period.Profit for the quarter ended March 2024 rises by 53.90% to Rs. 10348.00  millions from Rs. 6724.00 millions.The company reported a good operating profit of 15913.00 millions compared to 11759.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 51048.00 45540.00 12.09 194838.00 169625.00 14.86 194838.00 169625.00 14.86
Other Income 2127.00 1148.00 85.28 8623.00 5913.00 45.83 8623.00 5913.00 45.83
PBIDT 15913.00 11759.00 35.33 67887.00 48061.00 41.25 67887.00 48061.00 41.25
Interest 59.00 26.00 126.92 218.00 169.00 28.99 218.00 169.00 28.99
PBDT 15854.00 11733.00 35.12 67669.00 47892.00 41.29 67669.00 47892.00 41.29
Depreciation 2462.00 2367.00 4.01 9756.00 9232.00 5.68 9756.00 9232.00 5.68
PBT 13392.00 9366.00 42.99 57913.00 38660.00 49.80 57913.00 38660.00 49.80
TAX 3044.00 2642.00 15.22 14493.00 12532.00 15.65 14493.00 12532.00 15.65
Deferred Tax 342.00 323.00 5.88 875.00 3891.00 -77.51 875.00 3891.00 -77.51
PAT 10348.00 6724.00 53.90 43420.00 26128.00 66.18 43420.00 26128.00 66.18
Equity 834.00 833.00 0.12 834.00 833.00 0.12 834.00 833.00 0.12
PBIDTM(%) 31.17 25.82 20.72 34.84 28.33 22.97 34.84 28.33 22.97